Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen [Clinical Sciences]
Conclusions—
Both route of estrogen administration and progestogens were important determinants of IS. Our findings suggest that transdermal estrogens might be the safest option for short-term hormone therapy use.
Source: Stroke - Category: Neurology Authors: Canonico, M., Carcaillon, L., Plu-Bureau, G., Oger, E., Singh-Manoux, A., Tubert-Bitter, P., Elbaz, A., Scarabin, P.-Y. Tags: Cardiovascular Disease, Epidemiology, Risk Factors, Women Clinical Sciences Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Epidemiology | Health | Health Insurance | Heart | Hormonal Therapy | Hormones | Insurance | Ischemic Stroke | Neurology | Stroke | Study | Women